HK1072009A1 - Pharmaceutical desmopressin composition as solid dosage form and method for manufacturing thereof. - Google Patents

Pharmaceutical desmopressin composition as solid dosage form and method for manufacturing thereof.

Info

Publication number
HK1072009A1
HK1072009A1 HK05104919A HK05104919A HK1072009A1 HK 1072009 A1 HK1072009 A1 HK 1072009A1 HK 05104919 A HK05104919 A HK 05104919A HK 05104919 A HK05104919 A HK 05104919A HK 1072009 A1 HK1072009 A1 HK 1072009A1
Authority
HK
Hong Kong
Prior art keywords
dosage form
solid dosage
manufacturing
pharmaceutical composition
desmopressin
Prior art date
Application number
HK05104919A
Other languages
English (en)
Inventor
Hakan Lomryd
Helena Nicklasson
Lars-Erik Olsson
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34117527&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1072009(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of HK1072009A1 publication Critical patent/HK1072009A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK05104919A 2003-07-25 2005-06-13 Pharmaceutical desmopressin composition as solid dosage form and method for manufacturing thereof. HK1072009A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/626,857 US7022340B2 (en) 2003-07-25 2003-07-25 Pharmaceutical composition as solid dosage form and method for manufacturing thereof
EP03016945A EP1500390B1 (de) 2003-07-25 2003-07-25 Pharmazeutische Desmopressin-Zubereitung als feste Darreichungsform und Methode zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
HK1072009A1 true HK1072009A1 (en) 2005-08-12

Family

ID=34117527

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05104919A HK1072009A1 (en) 2003-07-25 2005-06-13 Pharmaceutical desmopressin composition as solid dosage form and method for manufacturing thereof.

Country Status (22)

Country Link
US (1) US7022340B2 (de)
EP (1) EP1500390B1 (de)
JP (1) JP4430673B2 (de)
KR (1) KR20050104331A (de)
AT (1) ATE301990T1 (de)
AU (1) AU2004260625B2 (de)
BR (1) BRPI0412905A (de)
CA (1) CA2490335C (de)
DE (1) DE60301351T2 (de)
DK (1) DK1500390T3 (de)
ES (1) ES2243840T3 (de)
HK (1) HK1072009A1 (de)
IL (1) IL187591A0 (de)
MX (1) MXPA06000903A (de)
NO (1) NO327328B1 (de)
NZ (1) NZ544104A (de)
PL (1) PL379704A1 (de)
PT (1) PT1500390E (de)
RU (1) RU2303439C2 (de)
SI (1) SI1500390T1 (de)
TW (1) TWI268782B (de)
WO (1) WO2005011640A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US7094545B2 (en) * 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
CN1826099B (zh) * 2003-07-25 2010-06-09 凡林有限公司 固体剂型药物组合物及其制造方法
ES2260563T3 (es) * 2003-11-13 2006-11-01 Ferring B.V. Paquete de blister y forma farmaceutica solida para ello.
US7018653B2 (en) * 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
CA2490601C (en) * 2003-12-29 2006-05-02 Ferring B.V. Method for preparing solid dosage form of desmopressin
SE528446C2 (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
CA2695634C (en) 2007-08-06 2018-01-23 Serenity Pharmaceuticals Corporation Methods and devices for desmopressin drug delivery
ES2319054B1 (es) 2007-08-06 2010-02-12 Gp Pharm S.A. Composicion farmaceutica oral de desmopresina.
US20090232896A1 (en) * 2008-03-11 2009-09-17 Mallinckrodt Inc. Use of Magnesium Stearate Dihydrate for Lubrication of Solid Pharmaceutical Compositions
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
DK3225250T3 (da) * 2008-05-21 2019-11-04 Ferring Bv Orodispersibel desmopressin til forlængelse af den indledende søvnperiode, som ikke forstyrres af nykturi
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
KR20110089265A (ko) * 2008-09-30 2011-08-05 미쓰이 가가쿠 가부시키가이샤 섬유 강화 수지 조성물 및 그의 성형체

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8306367L (sv) * 1983-11-18 1985-05-19 Ferring Ab Antidiuretiskt verkande farmaceutiskt preparat
US4675188A (en) * 1985-08-02 1987-06-23 Stauffer Chemical Company Granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting
US4820627A (en) * 1986-03-24 1989-04-11 Em Diagnostic Systems, Inc. Method of preparing particles suitable for tabletting into diagnostic reagents
US5482931A (en) 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
WO1995018602A1 (en) 1994-01-11 1995-07-13 Alkermes Controlled Therapeutics, Inc. ORAL DOSAGE FORM OF DESMOPRESSIN (dDAVP)
SE9400918L (sv) 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
US5849322A (en) 1995-10-23 1998-12-15 Theratech, Inc. Compositions and methods for buccal delivery of pharmaceutical agents
GB9526495D0 (en) 1995-12-23 1996-02-28 Knoll Ag Therapeutic agents
DE19602757A1 (de) * 1996-01-26 1997-07-31 Boehringer Mannheim Gmbh Feste Instant-Release-Darreichungsformen und Verfahren zu ihrer Herstellung
WO2000009423A1 (es) 1998-08-11 2000-02-24 Jaime Marti Sala Silo para almacenamiento de cuerpos huecos ligeros
AT409081B (de) 2000-02-16 2002-05-27 Gebro Pharma Gmbh Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
WO2001078696A2 (en) 2000-04-17 2001-10-25 Vectura Limited Formulations for use in inhaler devices
GB0009469D0 (en) * 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formalities for use in inhaler devices
PE20011227A1 (es) * 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
GB0010709D0 (en) 2000-05-03 2000-06-28 Vectura Ltd Powders for use a in dry powder inhaler
WO2002000197A1 (en) 2000-06-27 2002-01-03 Vectura Limited Method of making particles for use in a pharmaceutical composition
PL367957A1 (en) 2001-10-15 2005-03-07 Röhm Gmbh & Co.Kg Use of a copolymer to produce a galenic form containing a peptide or a protein as active agent
DE60307082D1 (de) 2002-05-07 2006-09-07 Ferring Bv In der mundhöhle dispergierbare phamarzeutische zusammensetzung mit desmopressin
EP1473029B1 (de) * 2003-04-30 2005-03-23 Ferring B.V. Feste Dosierungsform mit Desmopressin
US7094545B2 (en) * 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof

Also Published As

Publication number Publication date
TW200509995A (en) 2005-03-16
CA2490335A1 (en) 2005-01-25
EP1500390B1 (de) 2005-08-17
NZ544104A (en) 2008-06-30
DE60301351D1 (de) 2005-09-22
WO2005011640A2 (en) 2005-02-10
KR20050104331A (ko) 2005-11-02
RU2303439C2 (ru) 2007-07-27
ATE301990T1 (de) 2005-09-15
BRPI0412905A (pt) 2006-09-26
IL187591A0 (en) 2008-03-20
MXPA06000903A (es) 2006-05-04
US7022340B2 (en) 2006-04-04
PL379704A1 (pl) 2006-11-13
DE60301351T2 (de) 2006-01-19
AU2004260625A1 (en) 2005-02-10
NO20051896L (no) 2005-04-19
PT1500390E (pt) 2005-10-31
EP1500390A1 (de) 2005-01-26
SI1500390T1 (sl) 2006-02-28
RU2005141230A (ru) 2006-07-10
ES2243840T3 (es) 2005-12-01
CA2490335C (en) 2006-01-31
WO2005011640A3 (en) 2005-03-24
US20050019392A1 (en) 2005-01-27
AU2004260625B2 (en) 2007-12-06
NO327328B1 (no) 2009-06-08
TWI268782B (en) 2006-12-21
JP2007517762A (ja) 2007-07-05
JP4430673B2 (ja) 2010-03-10
DK1500390T3 (da) 2005-09-19

Similar Documents

Publication Publication Date Title
HK1072009A1 (en) Pharmaceutical desmopressin composition as solid dosage form and method for manufacturing thereof.
TW200518743A (en) Rapid dissolution formulation of a calcium receptor-active compound
TW200505406A (en) Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
MY148773A (en) Galenic formulations of organic compounds
WO2003022809A3 (en) Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
DE60104399D1 (de) Pulverformulierung zur inhalation
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
EA200301040A1 (ru) Способ производства фармацевтической композиции низкой дозы
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
ATE329581T1 (de) Pharmazeutische formulierung, die n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydr -2h-(1, 3)oxazino(3,2-a)indol-10-carboxamid oder ein entsprechendes salz hiervon enthält, sowie deren herstellungsprozess, welcher trockengranulierung beinhaltet
WO2006029210A3 (en) Acyclic 1,3-diamines and uses therefor
HK1075894A1 (en) Prucalopride-n-oxide
BE2016C017I2 (de)
NO20055016L (no) Farmasoytisk sammensetning som fast doseringsform og fremgangsmate for fremstilling derav

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170725